Back to Sumitomo Mitsui Trust Group, Inc. Sumitomo Mitsui Trust Group, Inc.

ARCTARCT

Showing 9 of 30 quarters

Position history for Sumitomo Mitsui Trust Group, Inc.Sumitomo Mitsui Trust Group, Inc.'s holdings in Arcturus Therapeutics Holdings Inc.

Yes. Sumitomo Mitsui Trust Group holds 1,689,107 shares of ARCT (Arcturus Therapeutics Holdings), worth $23.1M, as of its Q3 2026 13F filing. It reduced the position by 274,016 shares (-14.0%) from Q2 2026. Sumitomo Mitsui Trust Group has held ARCT since Q2 2019, across 30 quarterly 13F filings.

Current Value

$23.1M

Current Shares

1.7M

Total Value Change

-$29.7M

Total Shares Change

-586,608

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Decreased
1.7M
-14.0%
$23.1M0.0%$13.69
0
2026-Q2
Decreased
2M
-14.2%
$13.2M0.0%$6.72
0
2026-Q1
Increased
2.3M
+12.9%
$17.7M0.0%$7.72
32
2025-Q4
Increased
2M
+4.0%
$12.4M0.0%$6.13
29
2025-Q3
Increased
1.9M
+6.3%
$35.9M0.0%$18.43
31
2025-Q2
Decreased
1.8M
-4.9%
$23.8M0.0%$13.01
0
2025-Q1
Decreased
1.9M
-6.7%
$20.4M0.0%$10.59
0
2024-Q4
Decreased
2.1M
-9.3%
$35M0.0%$16.97
0
2024-Q3
Increased
2.3M
+45.6%
$52.8M0.0%$23.21
40

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used